NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02975206,"Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis",https://clinicaltrials.gov/study/NCT02975206,ATOMIK,COMPLETED,"Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis",YES,Pruritus|Atopic Dermatitis,DRUG: Serlopitant High Dose|DRUG: Placebo Oral Tablet|DRUG: Serlopitant Low Dose,"Change in WI-NRS From Baseline to Week 6, Worst Itch Numeric Rating Scale (WI-NRS). 11-point scale ranging from 0 (no itch) to 10 (worst itch imaginable). Higher scores indicate greater itch intensity. The primary outcome is the change in WI-NRS score between the visit and Baseline., Week 6 compared to Baseline","WI-NRS 4-point Responder Rate at Week 6, Worst Itch Numeric Rating Scale (WI-NRS). 11-point scale ranging from 0 (no itch) to 10 (worst itch imaginable). Higher scores indicate greater itch intensity. A 4-point responder is a subject who had at least a 4-point reduction in score between Week 6 and baseline., Week 6 compared to Baseline|Change in Quality of Life (ItchyQoL) From Baseline to Week 6, ItchyQoL is a 22-item pruritus-specific instrument that measures the degree to which pruritus affects quality-of-life. The responses to the items are Never (1), Rarely (2), Sometimes (3), Often (4) and All the Time (5). A higher score corresponds to a more adverse impact. The overall score is the average of the 22 items ranging from 1 to 5., Week 6 compared to Baseline",,Vyne Therapeutics Inc.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,484,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",MTI-103,2016-11,2018-01-16,2018-02-23,2016-11-29,2019-01-14,2021-05-20,"Study Site 332, Anniston, Alabama, United States|Study Site 363, Birmingham, Alabama, United States|Study Site 340, Hoover, Alabama, United States|Study Site 364, Glendale, Arizona, United States|Study Site 334, Cerritos, California, United States|Study Site 386, Encinitas, California, United States|Study Site 366, Fountain Valley, California, United States|Study Site 338, Los Angeles, California, United States|Study Site 383, North Hollywood, California, United States|Study Site 374, Oceanside, California, United States|Study Site 347, San Diego, California, United States|Study Site 356, San Diego, California, United States|Study Site 333, San Francisco, California, United States|Study Site 376, Santa Monica, California, United States|Study Site 358, Denver, Colorado, United States|Study Site 370, Jacksonville, Florida, United States|Study Site 331, Miami, Florida, United States|Study Site 348, Miami, Florida, United States|Study Site 378, Miami, Florida, United States|Study Site 353, Pinellas Park, Florida, United States|Study Site 368, Tampa, Florida, United States|Study Site 377, Tampa, Florida, United States|Study Site 369, Atlanta, Georgia, United States|Study Site 349, Savannah, Georgia, United States|Study Site 381, Chicago, Illinois, United States|Study Site 360, New Albany, Indiana, United States|Study Site 380, Bardstown, Kentucky, United States|Study Site 344, Louisville, Kentucky, United States|Study Site 379, Boston, Massachusetts, United States|Study Site 350, Warren, Michigan, United States|Study Site 371, Saint Joseph, Missouri, United States|Study Site 387, Las Vegas, Nevada, United States|Study Site 352, Berlin, New Jersey, United States|Study Site 375, Forest Hills, New York, United States|Study Site 373, Rochester, New York, United States|Study Site 341, High Point, North Carolina, United States|Study Site 355, Shelby, North Carolina, United States|Study Site 337, Oklahoma City, Oklahoma, United States|Study Site 345, Johnston, Rhode Island, United States|Study Site 362, Providence, Rhode Island, United States|Study Site 382, Anderson, South Carolina, United States|Study Site 343, Spartanburg, South Carolina, United States|Study Site 357, Chattanooga, Tennessee, United States|Study Site 365, Austin, Texas, United States|Study Site 335, Houston, Texas, United States|Study Site 359, Pflugerville, Texas, United States|Study Site 339, Plano, Texas, United States|Study Site 361, San Antonio, Texas, United States|Study Site 351, Draper, Utah, United States|Study Site 342, Norfolk, Virginia, United States|Study Site 336, Richmond, Virginia, United States|Study Site 367, Richmond, Virginia, United States","Study Protocol, https://storage.googleapis.com/ctgov2-large-docs/06/NCT02975206/Prot_000.pdf|Statistical Analysis Plan, https://storage.googleapis.com/ctgov2-large-docs/06/NCT02975206/SAP_001.pdf"
